Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4956 Monotherapy and in Combination With Saruparib in Advanced/Metastatic Solid Tumours
NCT07446855Phase 2Recruiting
- Sponsor
- AstraZeneca
- Start
- Mar 2026
- Primary completion
- Mar 2030
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of AZD4956 in solid tumor, breast cancer, ovarian cancer, prostate cancer (PCa), pancreatic cancer (PC), sponsored by AstraZeneca. Started Mar 2026; status: recruiting.
02
Drugs
AZD4956
03
Conditions
solid tumorbreast cancerovarian cancerprostate cancer (PCa)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07446855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07446855.